Qiming funds convert Alamar preferred in IPO
Alamar Biosciences, Inc. reported that investment vehicles affiliated with Qiming converted multiple series of preferred stock into equity tied to its initial public offering.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alamar Biosciences, Inc. reported that investment vehicles affiliated with Qiming converted multiple series of preferred stock into equity tied to its initial public offering. Qiming-related funds converted Series A-3, Series A-4, Series B and Series C preferred stock into Class B Common Stock, and each Class B share was then automatically reclassified into Common Stock immediately before the IPO.
All transactions were indirect, recorded at a price of $0.00 per share, and coded as conversions or other internal restructurings rather than market purchases or sales. The Qiming general partner entities may be deemed to share voting and dispositive power but disclaim beneficial ownership beyond their proportionate economic interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series A-3 Preferred Stock | 172,328 | $0.00 | $0.00 |
| Conversion | Series A-3 Preferred Stock | 6,404,332 | $0.00 | $0.00 |
| Conversion | Series A-4 Preferred Stock | 154,425 | $0.00 | $0.00 |
| Conversion | Series A-4 Preferred Stock | 5,738,971 | $0.00 | $0.00 |
| Conversion | Series B Preferred Stock | 113,625 | $0.00 | $0.00 |
| Conversion | Series B Preferred Stock | 4,222,738 | $0.00 | $0.00 |
| Conversion | Series C Preferred Stock | 3,882,451 | $0.00 | $0.00 |
| Conversion | Series C Preferred Stock | 4,648,194 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 185,163 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 6,881,410 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 1,605,645 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 1,922,329 | $0.00 | $0.00 |
| Other | Class B Common Stock | 185,163 | $0.00 | $0.00 |
| Other | Class B Common Stock | 6,881,410 | $0.00 | $0.00 |
| Other | Class B Common Stock | 1,605,645 | $0.00 | $0.00 |
| Other | Class B Common Stock | 1,922,329 | $0.00 | $0.00 |
| Other | Common Stock | 185,163 | $0.00 | $0.00 |
| Other | Common Stock | 6,881,410 | $0.00 | $0.00 |
| Other | Common Stock | 1,605,645 | $0.00 | $0.00 |
| Other | Common Stock | 1,922,329 | $0.00 | $0.00 |
Footnotes (7)
- F1. Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date.
- F2. Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date.
- F3. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
- F4. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
- F5. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
- F6. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
- F7. Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock.
Key Figures
Key Terms
Class B Common Stock financial
Series A-3 Preferred Stock financial
Series A-4 Preferred Stock financial
Series B Preferred Stock financial
Conversion of derivative security financial
disclaims beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Qiming entities report in the Alamar Biosciences (ALMR) Form 4?
Were there any open-market buys or sells in this Alamar Biosciences (ALMR) Form 4?
What does the Form 4 say about Alamar Biosciences (ALMR) Class B Common Stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.